Tap the link in our bio
Research published in clinical gastroenterology journals found that semaglutide increased gastric retention of solid food by 25.5% at the 2-hour mark, 38.0% at 3 hours, and 30.0% at 4 hours compared to baseline
If any patient is concerned about their treatment, they should discuss this with their clinician. In March this year, NICE recommended a weekly injection of semaglutide, manufactured by Novo Nordisk under the brand name Wegovy, for adults who have at least one weight-related comorbidity and a body mass index (BMI) of at least 35kg/m2
In the study by Kong et al
Dandona P, Weinstock R, Thusu K, Abdel-Rahman E, Aljada A, Wadden T
SGLT2 Inhibitors : This class of medications works by helping the kidneys remove excess glucose from the bloodstream